Physician profile
Willie E Lawrence
NPI 1851345466
$3,666.34
in general payments reported to CMS, 2019-2025
24 companies · $786 in 2025
The $786 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $397 · 2021: $403 · 2022: $472 · 2023: $443 · 2024: $799 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Education: $80.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.21 |
| Education | $80.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $556.95 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $344.80 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $341.48 | 2021-2025 | |
| Novo Nordisk INC | $315.60 | 2023-2024 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $295.48 | 2019-2025 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $283.73 | 2019-2025 | Lifevest |
| Medtronic, INC. | $282.21 | 2021-2025 | Symplicity G3 |
| Janssen Pharmaceuticals, INC | $215.39 | 2020-2022 | |
| Boston Scientific Corporation | $144.33 | 2022-2023 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $135.88 | 2020-2025 | Onpattro, Amvuttra |
| Medtronic Vascular, INC. | $124.52 | 2019-2020 | |
| Pfizer INC. | $122.19 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.77 | 2019-2024 | Jardiance |
| Biosense Webster, INC. | $71.19 | 2022 | |
| Idorsia Pharmaceuticals US INC | $60.41 | 2024 | Tryvio |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $57.88 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $35.08 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $33.71 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $32.79 | 2021-2022 | |
| Abiomed | $30.83 | 2021 | |
| Irhythm Technologies, INC. | $26.13 | 2024 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Astellas Pharma US INC | $16.16 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.